Clinical Potential of Expanded Noninvasive Prenatal Testing for Detection of Aneuploidies and Microdeletion/Microduplication Syndromes
Tóm tắt
Từ khóa
Tài liệu tham khảo
Dai L, Zhu J, Liang J, Wang YP, Wang H, Mao M. Birth defects surveillance in China. World J Pediatr. 2011;7(4):302–10.
Li C, Zhang J, Li J, Qiao G, Zhan Y, Xu Y, et al. BACs-on-beads assay for the prenatal diagnosis of microdeletion and microduplication syndromes. Mol Diagn Ther. 2021;25(3):339–49.
Driscoll DA, Gross S. Clinical practice: prenatal screening for aneuploidy. N Engl J Med. 2009;360(24):2556–62.
Zheng J, Lu H, Li M, Guan Y, Yang F, Xu M, et al. The clinical utility of non-invasive prenatal testing for pregnant women with different diagnostic indications. Front Genet. 2020;11:624.
Zhang Y, Xu H, Zhang W, Liu K. Non-invasive prenatal testing for the detection of trisomy 13, 18, and 21 and sex chromosome aneuploidies in 68,763 cases. Front Genet. 2022;13: 864076.
Zheng Y, Li J, Zhang J, Yang H. The accuracy and feasibility of noninvasive prenatal testing in a consecutive series of 20,626 pregnancies with different clinical characteristics. J Clin Lab Anal. 2022;36(10): e24660.
Rose NC, Barrie ES, Malinowski J, Jenkins GP, McClain MR, LaGrave D, et al. Systematic evidence-based review: the application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies. Genet Med. 2022;24(7):1379–91.
Dungan JS, Klugman S, Darilek S, Malinowski J, Akkari YMN, Monaghan KG, et al. Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2023;25(2): 100336.
Xiang L, Zhu J, Deng K, Li Q, Tao J, Li M, et al. Non-invasive prenatal testing for the detection of trisomies 21, 18, and 13 in pregnant women with various clinical indications: a multicenter observational study of 1,854,148 women in China. Prenat Diagn. 2023;43(8):1036–43.
Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175–84.
Carlson LM, Vora NL. Prenatal diagnosis: screening and diagnostic tools. Obstet Gynecol Clin North Am. 2017;44(2):245–56.
Alberry MS, Aziz E, Ahmed SR, Abdel-Fattah S. Non invasive prenatal testing (NIPT) for common aneuploidies and beyond. Eur J Obstet Gynecol Reprod Biol. 2021;258:424–9.
Liang D, Cram DS, Tan H, Linpeng S, Liu Y, Sun H, et al. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes. Genet Med. 2019;21(9):1998–2006.
Shi P, Wang Y, Liang H, Hou Y, Chen D, Zhao G, et al. The potential of expanded noninvasive prenatal screening for detection of microdeletion and microduplication syndromes. Prenat Diagn. 2021;41(10):1332–42.
Parks M, Court S, Bowns B, Cleary S, Clokie S, Hewitt J, et al. Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage. Eur J Hum Genet. 2017;25(4):416–22.
New MI, Tong YK, Yuen T, Jiang P, Pina C, Chan KC, et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab. 2014;99(6):E1022–30.
Parks M, Court S, Cleary S, Clokie S, Hewitt J, Williams D, et al. Non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies by relative haplotype dosage. Prenat Diagn. 2016;36(4):312–20.
Chiu RW, Chan KC, Gao Y, Lau VY, Zheng W, Leung TY, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA. 2008;105(51):20458–63.
Chen Y, Lu L, Zhang Y, Wang F, Ni Y, Wang Q, et al. Clinical application of expanded noninvasive prenatal testing for fetal chromosome abnormalities in a cohort of 39,580 pregnancies. Am J Med Genet A. 2022;188(5):1426–34.
Wang JW, Lyu YN, Qiao B, Li Y, Zhang Y, Dhanyamraju PK, et al. Cell-free fetal DNA testing and its correlation with prenatal indications. BMC Pregnancy Childbirth. 2021;21(1):585.
Wang C, Tang J, Tong K, Huang D, Tu H, Li Q, et al. Expanding the application of non-invasive prenatal testing in the detection of foetal chromosomal copy number variations. BMC Med Genomics. 2021;14(1):292.
Yuan X, Yong W, Dai L, Wang W, Wu L. The role of non-invasive prenatal testing and ultrasound in prenatal screening of fetal chromosomal abnormalities in singleton: a retrospective study. Ann Transl Med. 2023;11(2):111.
Liu S, Chang Q, Yang F, Xu Y, Jia B, Wu R, et al. Non-invasive prenatal test findings in 41,819 pregnant women: results from a clinical laboratory in southern China. Arch Gynecol Obstet. 2023;308(3):787–95.
Zheng Y, Wan S, Dang Y, Song T, Chen B, Zhang J. Clinical experience regarding the accuracy of NIPT in the detection of sex chromosome abnormality. J Gene Med. 2020;22(8): e3199.
Zhang B, Lu BY, Yu B, Zheng FX, Zhou Q, Chen YP, et al. Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood. J Int Med Res. 2017;45(2):621–30.
Zhao G, Dai P, Wang C, Liu L, Zhao X, Kong X. Clinical application of noninvasive prenatal testing for sex chromosome aneuploidies in Central China. Front Med (Lausanne). 2021;8: 672211.
Xue H, Yu A, Lin M, Chen X, Guo Q, Xu L, et al. Efficiency of expanded noninvasive prenatal testing in the detection of fetal subchromosomal microdeletion and microduplication in a cohort of 31,256 single pregnancies. Sci Rep. 2022;12(1):19750.
Li C, Chen B, Zheng J, Cheng L, Song T, Guo F, et al. Prenatal diagnosis of BACs-on-beads assay in 3647 cases of amniotic fluid cells. Reprod Sci. 2019;26(7):1005–12.
American College of O, Gynecologists' Committee on Practice B-O, Committee on G, Society for Maternal-Fetal M. Screening for fetal chromosomal abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol. 2020;136(4):e48–69.
Lo LM, Shiau CS, Chen KC, Shaw SWS, Benn P. Screening for 22q11.2 deletion syndrome by two non-invasive prenatal testing methodologies: a case with discordant results. Taiwan J Obstet Gynecol. 2019;58(1):40–2.
Blagowidow N, Nowakowska B, Schindewolf E, Grati FR, Putotto C, Breckpot J, et al. Prenatal screening and diagnostic considerations for 22q11.2 microdeletions. Genes (Basel). 2023;14(1):160.
Bevilacqua E, Jani JC, Chaoui R, Suk EA, Palma-Dias R, Ko TM, et al. Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletion in a large clinical cohort. Ultrasound Obstet Gynecol. 2021;58(4):597–602.
Hsu WW, Hsieh CJ, Lee CN, Chen CL, Lin MW, Kang J, et al. Complication rates after chorionic villus sampling and midtrimester amniocentesis: a 7-year national registry study. J Formos Med Assoc. 2019;118(7):1107–13.
Aird D, Ross MG, Chen WS, Danielsson M, Fennell T, Russ C, et al. Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol. 2011;12(2):R18.
Shin SC, Ahn DH, Kim SJ, Lee H, Oh TJ, Lee JE, et al. Advantages of single-molecule real-time sequencing in high-GC content genomes. PLoS ONE. 2013;8(7): e68824.
Ye X, Lin S, Song X, Tan M, Li J, Wang J, et al. Identification of copy number variants by NGS-based NIPT at low sequencing depth. Eur J Obstet Gynecol Reprod Biol. 2021;256:297–301.
Van Opstal D, Srebniak MI. Cytogenetic confirmation of a positive NIPT result: evidence-based choice between chorionic villus sampling and amniocentesis depending on chromosome aberration. Expert Rev Mol Diagn. 2016;16(5):513–20.
Rosner M, Kolbe T, Hengstschlager M. Fetomaternal microchimerism and genetic diagnosis: on the origins of fetal cells and cell-free fetal DNA in the pregnant woman. Mutat Res Rev Mutat Res. 2021;788:108399.
Bu X, Zhou S, Li X, Li S, Li H, Ding S, et al. A retrospective single-center analysis of prenatal diagnosis and follow-up of 626 Chinese patients with positive non-invasive prenatal screening results. Front Genet. 2022;13: 965106.
Wang Y, Chen Y, Tian F, Zhang J, Song Z, Wu Y, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem. 2014;60(1):251–9.